EGFR activity in Her-2 overexpressing metastatic breast cancer: evidence for simultaneous phosphorylation of Her-2/neu and EGFR

MLA

Gernot Hudelist, et al. “EGFR Activity in Her-2 Overexpressing Metastatic Breast Cancer: Evidence for Simultaneous Phosphorylation of Her-2/Neu and EGFR.” European Journal of Cancer Supplements, vol. 4, Mar. 2006, p. 132. EBSCOhost, https://doi.org/10.1016/s1359-6349(06)80310-1.

APA

Gernot Hudelist, Daphne Gschwantler-Kaulich, Klaus Czerwenka, Christian F. Singer, Ruth Müller, E. Rücklinger, Wolfgang J. Köstler, & Ernst Kubista. (2006). EGFR activity in Her-2 overexpressing metastatic breast cancer: evidence for simultaneous phosphorylation of Her-2/neu and EGFR. European Journal of Cancer Supplements, 4, 132. https://doi.org/10.1016/s1359-6349(06)80310-1

Chicago

Gernot Hudelist, Daphne Gschwantler-Kaulich, Klaus Czerwenka, Christian F. Singer, Ruth Müller, E. Rücklinger, Wolfgang J. Köstler, and Ernst Kubista. 2006. “EGFR Activity in Her-2 Overexpressing Metastatic Breast Cancer: Evidence for Simultaneous Phosphorylation of Her-2/Neu and EGFR.” European Journal of Cancer Supplements 4 (March): 132. doi:10.1016/s1359-6349(06)80310-1.